ERAP1 and gastric adenocarcinoma: ERAP1 and ERAP2 expression is also frequently altered in melanoma, acute myeloid leukemia, gastric adenocarcinoma, HPV-induced malignancies and renal clear cell carcinoma, as another immune escape mechanism [38,39,40,41].